XoWiki mobile view
 

 

Active Studies

CURB-2 Study

Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

EXPRESS+

Expression of stress markers in MSM living with HIV receiving contingency management for methamphetamine use disorder (a.k.a "EXPRESS+")

HPTN 094

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care.

IMSTI

Inflammation in Methamphetamine and STIs

M3 Study

Phase 1 safety-interaction study of mirtazapine for the treatment of methamphetamine use disorder

MURB Study

MURB Study: Randomized, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB)

PURPOSE 2

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapvir for HIV Pre-Exposure Prophylaxis (PrEP) in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary people 18 Years of Age or Older who Have Sex with Male Partners and are at Risk of HIV Infection.